Ameriprise Financial, Inc. 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 10:56 am Sale | 2021-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | AMERIPRISE FINANCIAL INC AMP | 285 0.000% | -2,370,951 (-99.99%) | Filing |
| 2021-02-12 12:08 pm Purchase | 2020-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | AMERIPRISE FINANCIAL INC AMP | 2,371,236 7.500% | 1,221,658 (+106.27%) | Filing |